E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/17/2011 in the Prospect News Convertibles Daily.

Convertibles Calendar

OCTOBER

REGENERON PHARMACEUTICALS INC. (Nasdaq: REGN): $400 million convertible senior notes due 2016; $60 million over-allotment option; Rule 144A offering; proceeds to cover cost of convertible note hedge transactions and for general corporate purposes; Tarrytown, N.Y.-based biopharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.